News Articles Tagged: CNS Disorders Treatment

S(+)-Baclofen: A Key Pharmaceutical Intermediate for CNS Disorders

Explore the benefits and applications of S(+)-Baclofen (CAS 66514-99-6), a vital GABA-B receptor agonist. Learn why this pharmaceutical intermediate is crucial for treating spasticity and CNS disorders. Contact our China-based manufacturer for reliable supply.

Exploring the Synthesis Pathways of Thiodiglycolic Anhydride for Enhanced Drug Development

NINGBO INNO PHARMCHEM CO.,LTD. focuses on providing Thiodiglycolic Anhydride, a key intermediate, and explores its synthesis pathways to aid in the development of new treatments for CNS disorders.

GABA-B Receptor Agonists: Mechanisms and Therapeutic Potential for Anxiety and Cognitive Function

Delve into the science behind GABA-B receptor agonists, including (R)-3-Amino-4-(3-fluorophenyl)butyric acid HCl, and their therapeutic promise for anxiety disorders and cognitive enhancement.

The Role of 7-(4-Chlorobutoxy)quinolin-2(1H)-one in Treating CNS Disorders: A Synthesis Perspective

Explore the synthesis and application of 7-(4-Chlorobutoxy)quinolin-2(1H)-one, a vital intermediate for CNS disorder treatments, with insights from NINGBO INNO PHARMCHEM CO.,LTD.